Chaki S, Guo D F, Yamano Y, Ohyama K, Tani M, Mizukoshi M, Shirai H, Inagami T
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee.
Kidney Int. 1994 Dec;46(6):1492-5. doi: 10.1038/ki.1994.427.
Binding of angiotensin II (Ang II) to its receptor type 1A (AT1A) is known to trigger its internalization. We studied the role of cytosolic segments of AT1A in the internalization, and obtained results indicating a functional role of the cytosolic carboxyl terminal tail of AT1A in the internalization. Deletion of 50 amino acids from the carboxyl terminus abolished the receptor internalization. Deletion mutants lacking 13 and 32 amino acid residues in the carboxyl terminal cytosolic region were internalized to the same extent as wild type AT1A; however, internalization of a mutant lacking the last 42 residues was partially suppressed. Thus, residues 310 through 327 were shown to be essential for the internalization. We propose that a short domain in the cytoplasmic tail (residues 310 to 327) may play a dominant role in the agonist-induced receptor internalization of AT1A. Our results also suggest that the molecular determinants of the AT1A receptor involved in receptor internalization are distinct from those participating in the desensitization process.
已知血管紧张素II(Ang II)与其1A型受体(AT1A)结合会引发其内化。我们研究了AT1A胞质区段在内化中的作用,并获得结果表明AT1A胞质羧基末端尾巴在内化中具有功能作用。从羧基末端缺失50个氨基酸会消除受体内化。在羧基末端胞质区域缺失13和32个氨基酸残基的缺失突变体与野生型AT1A的内化程度相同;然而,缺失最后42个残基的突变体的内化被部分抑制。因此,已表明310至327位残基对于内化至关重要。我们提出,胞质尾巴中的一个短结构域(310至327位残基)可能在激动剂诱导的AT1A受体内化中起主导作用。我们的结果还表明,参与受体内化的AT1A受体的分子决定因素与参与脱敏过程的因素不同。